Spiegel, Peter – Trademark Portfolio
Entity Type: 01
Spiegel, Peter has 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). The portfolio includes 0 registered trademarks and 2 pending applications. Filings span 7 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 9 (Computers & Electronics). This trademark owner is based in Austin, TX.
107 Barsana Road
Austin, TX 78737
Showing of trademarks Trademarks
Trademark Classifications
Spiegel, Peter's trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Machines and machine tools; motors and engines; machine coupling and transmission components
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Education; providing of training; entertainment; sporting and cultural activities
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Spiegel, Peter have?
Spiegel, Peter has 13 U.S. trademarks filed with the USPTO. Of these, 2 pending, 8 abandoned, 3 cancelled.
What trademark classes does Spiegel, Peter file in?
Spiegel, Peter files trademarks across 7 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 7 (Machinery), Class 16 (Paper Goods), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What is Spiegel, Peter's trademark registration success rate?
Spiegel, Peter has a 0% trademark registration rate, with 0 out of 11 resolved applications resulting in successful registration. Currently, 2 applications are pending review.